RevBio (formerly LaunchPad Medical)
Lowell, US · 2 known investors
Find your way into RevBio (formerly LaunchPad Medical)
190 people in our graph share verified history with the RevBio (formerly LaunchPad Medical) team — schools, employers, funds. One of them is your warm intro.
Birgitteunlockedknows BRIAN HESS · together at MIT Sloan School of Management (overlapped)
×5knows the team · via University of Wisconsin-Madison
×5knows the team · via MIT Sloan School of Management
knows the team · via Kimberly-Clark
RevBio develops a biomimetic bone adhesive platform derived from marine biology for bone repair and regenerative applications across dental, orthopedic, and neurosurgical indications. The company is conducting first-in-human clinical trials on its regenerative bone glue technology.
Founders & leadership
BH
Brian HessinChief Executive Officer, FounderBrian Hess is Chief Executive Officer and Founder of RevBio, a clinical-stage medical device company developing a bone adhesive platform for orthopedic, dental, and neurosurgical applications.
Investors · 2
Non-dilutive funding · 8 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $2.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $375K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $197.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does RevBio (formerly LaunchPad Medical) do?
- RevBio develops a biomimetic bone adhesive platform derived from marine biology for bone repair and regenerative applications across dental, orthopedic, and neurosurgical indications. The company is conducting first-in-human clinical trials on its regenerative bone glue technology.
- Who founded RevBio (formerly LaunchPad Medical)?
- RevBio (formerly LaunchPad Medical) was founded by Brian Hess.
- Who are RevBio (formerly LaunchPad Medical)'s investors?
- RevBio (formerly LaunchPad Medical)'s investors include Beacon Angels, Boston Harbor Angels.
- Where is RevBio (formerly LaunchPad Medical) headquartered?
- RevBio (formerly LaunchPad Medical) is headquartered in Lowell, US.